Ubs Group Ag Inspire Medical Systems, Inc. Transaction History

Ubs Group Ag

$555 Billion
Q2 2025

A detailed history of Ubs Group Ag transactions in Inspire Medical Systems, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 430,694 shares of INSP stock, worth $33.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

430,694

Previous 485,179 11.23%

Holding current value

$33.8 Million

Previous $77.3 Million 27.68%

% of portfolio

0.01%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$127.18 - $161.88 $6.93 Million - $8.82 Million	-54,485 Reduced 11.23%	430,694 $55.9 Million
Q1 2025 May 13, 2025	BUY	$157.24 - $215.42 $19.1 Million - $26.2 Million	121,624 Added 33.45%	485,179 $77.3 Million
Q4 2024 Feb 14, 2025	BUY	$172.7 - $214.93 $53.3 Million - $66.3 Million	308,412 Added 559.29%	363,555 $67.4 Million
Q3 2024 Nov 14, 2024	SELL	$125.79 - $216.71 $334,727 - $576,665	-2,661 Reduced 4.6%	55,143 $11.6 Million
Q2 2024 Aug 13, 2024	BUY	$133.83 - $251.19 $3.43 Million - $6.43 Million	25,617 Added 79.59%	57,804 $7.74 Million
Q1 2024 May 13, 2024	SELL	$165.3 - $226.0 $162,985 - $222,836	-986 Reduced 2.97%	32,187 $6.91 Million
Q4 2023 Feb 09, 2024	BUY	$125.26 - $203.83 $296,365 - $482,261	2,366 Added 7.68%	33,173 $6.75 Million
Q3 2023 Nov 09, 2023	SELL	$185.0 - $326.08 $624,930 - $1.1 Million	-3,378 Reduced 9.88%	30,807 $6.11 Million
Q2 2023 Aug 11, 2023	SELL	$226.52 - $324.64 $3.19 Million - $4.58 Million	-14,102 Reduced 29.2%	34,185 $11.1 Million
Q1 2023 May 12, 2023	BUY	$229.06 - $278.01 $1.75 Million - $2.13 Million	7,656 Added 18.84%	48,287 $11.3 Million
Q4 2022 Feb 08, 2023	BUY	$164.02 - $259.76 $4.06 Million - $6.43 Million	24,747 Added 155.8%	40,631 $10.2 Million
Q3 2022 Nov 10, 2022	BUY	$170.68 - $226.46 $207,205 - $274,922	1,214 Added 8.28%	15,884 $2.82 Million
Q2 2022 Aug 10, 2022	SELL	$147.53 - $266.6 $1.02 Million - $1.85 Million	-6,922 Reduced 32.06%	14,670 $2.68 Million
Q1 2022 May 16, 2022	BUY	$193.94 - $261.91 $373,334 - $504,176	1,925 Added 9.79%	21,592 $5.54 Million
Q4 2021 Feb 14, 2022	BUY	$207.57 - $280.17 $1.06 Million - $1.43 Million	5,111 Added 35.11%	19,667 $4.52 Million
Q3 2021 Nov 15, 2021	SELL	$170.0 - $258.58 $59,330 - $90,244	-349 Reduced 2.34%	14,556 $3.39 Million
Q2 2021 Aug 13, 2021	SELL	$164.93 - $242.23 $214,738 - $315,383	-1,302 Reduced 8.03%	14,905 $2.88 Million
Q1 2021 May 12, 2021	BUY	$182.45 - $249.25 $221,859 - $303,088	1,216 Added 8.11%	16,207 $3.36 Million
Q4 2020 Feb 11, 2021	SELL	$119.35 - $200.46 $41,414 - $69,559	-347 Reduced 2.26%	14,991 $2.82 Million
Q3 2020 Nov 12, 2020	SELL	$87.5 - $130.91 $385,262 - $576,396	-4,403 Reduced 22.3%	15,338 $1.98 Million
Q2 2020 Jul 31, 2020	BUY	$49.5 - $97.93 $362,835 - $717,826	7,330 Added 59.06%	19,741 $1.72 Million
Q1 2020 May 01, 2020	SELL	$41.62 - $89.92 $707 - $1,528	-17 Reduced 0.14%	12,411 $748,000
Q4 2019 Feb 14, 2020	BUY	$52.12 - $75.0 $38,933 - $56,025	747 Added 6.4%	12,428 $922,000
Q3 2019 Nov 14, 2019	BUY	$61.02 - $70.19 $71,454 - $82,192	1,171 Added 11.14%	11,681 $713,000
Q2 2019 Aug 14, 2019	SELL	$47.07 - $60.71 $31,913 - $41,161	-678 Reduced 6.06%	10,510 $637,000
Q1 2019 May 14, 2019	BUY	$39.48 - $62.0 $332,737 - $522,536	8,428 Added 305.36%	11,188 $635,000
Q4 2018 Feb 14, 2019	SELL	$37.07 - $52.58 $651,838 - $924,566	-17,584 Reduced 86.43%	2,760 $116,000
Q3 2018 Nov 14, 2018	BUY	$36.8 - $56.99 $215,647 - $333,961	5,860 Added 40.46%	20,344 $856,000
Q2 2018 Aug 14, 2018	BUY	$24.05 - $39.5 $348,340 - $572,118	14,484 New	14,484 $517,000

Others Institutions Holding INSP

# of Institutions

403

Shares Held

30.2M

Call Options Held

117K

Put Options Held

148K

View Full List

About Inspire Medical Systems, Inc.

Ticker INSP
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 28,788,600
Market Cap $2.26B
Description
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for m...

More about INSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account